Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Carcinoma, Hepatocellular × 4-toluenesulfonamide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 1

Interventions

Sorafenib 42 lenvatinib 39 apatinib 22 sintilimab 21 Fluorouracil 20 camrelizumab 19 Oxaliplatin 17 tislelizumab 14 Hepatectomy 14 Leucovorin 13 Radiofrequency Ablation 12 Radiotherapy 10 Folfox protocol 10 Doxorubicin 10 toripalimab 9 Radiosurgery 9 Epirubicin 9 Bevacizumab 9 Immune Checkpoint Inhibitors 8 Ethiodized Oil 8 regorafenib 7 donafenib 7 Neoadjuvant Therapy 7 Injections 7 pembrolizumab 6 durvalumab 6 anlotinib 6 Nivolumab 6 Immunotherapy 6 spartalizumab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03447951 2023-09-13

OASES

Gongwin Biopharm Co., Ltd.

Phase 2 Unknown

Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡